Kelly Chibale's extraordinary journey is marked by an impressive array of recognitions and accolades that affirm his stellar contributions to science, innovation and leadership.
From being elected a
Fellow of the University of Cape Town
(UCT) and the Royal Society of South Africa in 2009 to receiving the esteemed
Royal Society (UK) Africa Prize in 2023, each accolade is a testament to his exceptional leadership and groundbreaking work in drug discovery for African endemic diseases.
Honorary Fellowship – Queens’ College, University of Cambridge
In December 2024, Kelly Chibale was elected and admitted as an Honorary Fellow of Queens’ College, University of Cambridge – his alma mater where he completed his PhD in Chemistry. This is the highest honour the College can bestow on an individual, reflecting their exceptional achievements and contributions.
As noted by the President of Queens’ College, Dr Mohamed A. El-Erian: “This is the highest honour that we, as a College, can bestow and reflects our admiration for you as a person and your wonderful achievements to date.”
Kelly’s Fellowship was officially conferred on 13 December 2024, a moment celebrated in write-ups by both Queens’ College and the Yusuf Hamied Department of Chemistry, where he pursued his doctoral studies.
Pictured: (top) Kelly with Dr Mohamed A. El-Erian, President of Queens’ College, (bottom) Kelly with fellow Honorary Fellows and the President of Queens’ College.
Kelly Chibale Elected to United States National Academy of Medicine (NAM)
Kelly Chibale, PhD, has been elected as one of the 10 international members of the prestigious United States National Academy of Medicine (NAM). This honour recognises Kelly’s pioneering work in drug discovery and development, particularly in tackling infectious diseases on the African continent.
Kelly’s election to NAM highlights his leadership in global health and his exceptional contributions to advancing medical science in Africa. Notably, he has led international teams to discover the first small molecule clinical candidate researched on African soil by an African-led team. This recognition is a testament to Kelly’s unwavering commitment to improving health outcomes and fostering scientific innovation.
Kelly extends his heartfelt gratitude to his academic group, H3D team members – past and present – as well as his research collaborators and funders for their invaluable support in achieving this milestone.
Full press release here: https://nam.edu/national-academy-of-medicine-elects-100-new-members-2024/
Named the first Editor-In-Chief (EIC) from Africa of an American Chemical Society (ACS) publication when appointed EIC of ACS Medicinal Chemistry Letters, 2023 | Read More ▸
Awarded Royal Society (UK) Africa Prize 2023 ‘For exceptional leadership and groundbreaking work in drug discovery for African endemic diseases’
Awarded Schmidt Sciences AI2050 Senior Fellowship 2023. The AI2050 Senior Fellowship supports established leaders who have made significant contributions to their field. Senior Fellows are highly accomplished individuals working on approaches for increasing the beneficial promise of AI. The breadth of their collective projects showcases the range of work that will be critical to answer the AI2050 motivating question.
Awarded Honorary Doctorate of the Faculty of Science, University of Basel (Switzerland), 2023, in ‘honor of exceptional and inspiring Curriculum vitae, outstanding academic achievements and continuous and ongoing support of the Swiss Tropical and Public Health Institute, an associate Institute of the University of Basel.
Named as one of the 25 standout voices in African public health by Harvard University’s Public Health magazine, 12 May 2022. | Read More ▸
Named as one of the 22 black biotech leaders in honour of Juneteenth in the USA, 17 June 2021. The list, published by the Timmerman Report, celebrates innovative black leaders who are change-makers in their respective fields. | Read More ▸
Named as one of the world’s top 60 most influential/ inspirational leaders in the pharmaceutical industry (one of the top 20 inspirational medicine makers in the field of small molecules) on The Medicine Maker's 2020 and 2021 Power Lists.
Named as one of the 100 Most Influential Africans by New African magazine for 2019 | Read More ▸
South African National Research Foundation (NRF) A-rating, 2018
Named as one of Fortune Magazine’s World’s 50 Greatest Leaders for 2018 | Read More ▸
Awarded South African Chemical Institute (SACI) Gold Medal for 2018
Elected Member of the Academy of Science of South Africa (ASSAf), 2018
Elected Fellow of the African Academy of Science (FAAS), 2018
Named one of the 2017 Quartz Africa Innovators | Read More ▸
Named as one of the most highly prolific authors for the American Chemical Society (ACS)’s Journal of Medicinal Chemistry on the Journal Stars website, 2017. Also: One of 9 Authors worldwide who have published the most articles in the journal in the previous 5 years (2012-2016). | Read More ▸
Awarded two year (2017-2018) Visiting Cheney Fellowship with the Faculty of Maths and Physical Sciences-School of Chemistry and Faculty of Biological Sciences-Astbury Centre for Structural Molecular Biology, University of Leeds, UK, 2016
Awarded South African Medical Research Council (SAMRC) Gold Medal for 2016
Featured among the RSC 175 Faces of Chemistry, 2015
Invited to become a Fellow of the Royal Society of Chemistry (RSC), UK, in recognition of significant contributions to the chemical sciences, and in particular to contributions to drug discovery, 2014
Awarded Medicines for Malaria Venture 2012 Project of the Year for delivering MMV390048 as a preclinical candidate,2013
Awarded South African Medical Research Council (MRC) Silver Medal for 2013
Awarded NRF Special Recognition Award: Champion of Research Capacity Development at South African Higher Education Institutions (HEIs) for 2012
Awarded the Alan Pifer Research Award for 2011.This is the UCT Vice Chancellor’s award made annually “to a single researcher at UCT in recognition of outstanding research that demonstrates relevance to the advancement and welfare of South Africa’s disadvantaged people”.
Winner/recipient of the 2010/11 National Science and Technology Forum (NSTF)-BHP Billiton Awards in the category; TW Kambule NRF Senior Black Researcher. For outstanding contributions to science, technology and innovation over the last 5-10 years including specific recognition for establishing Africa’s first integrated modern drug discovery centre (H3D) and setting up various modern technology platforms for the discovery of potential medicines.
All Rights Reserved | Dr.Kelly Chibale | Privacy Policy